Dr Isolda Romero-Canelón BSc, MSc, PgCert, PhD, MRSC

• PhD, Department of Chemistry, University of Warwick, UK
• Warwick Interdisciplinary Science Postgraduate Certificate in Transferable Skills, University of Warwick, UK
• MSc, Department of Chemistry, University of Los Andes, Venezuela
• Basic university teaching training postgraduate certificate. University of Los Andes. Venezuela
• BSc equivalent, Department of Chemistry, University of Los Andes, Venezuela

• MPharm: Chemistry for Pharmacists

• Member of the Royal Society of Chemistry (MRSC)
• Member of the Biochemical Society
• Member of the European Association for Cancer Research
• Regular reviewer for the following journals: Chemical Science, ACS Inorganic Chemistry, Transition Metal Chemistry, RSC Advances, BMC Cancer, Dalton Transactions

Appointments held:           

2017      Lecturer in Medicinal and Pharmaceutical Chemistry, University of Birmingham, UK

2017      Visiting Associate Professor, Department of Chemistry, University of Warwick, UK

2016      Senior Research Fellow, Department of Chemistry, University of Warwick, UK

2012-15 ERC Post-Doctoral Research Fellow, Department of Chemistry, UoW, UK

2013      Aggregate* Professor Inorganic Chemistry. University of Los Andes. Venezuela

2007-12 Assistant* Professor Inorganic Chemistry. University of Los Andes. Venezuela. (On study leave Oct 2009- Dec 2012)      

2005-7   Instructor*. Inorganic Chemistry. University of Los Andes. Venezuela

*according to the Venezuelan academic system, university tenure positions are established through five ranks as: Instructor, Assistant Professor, Aggregate Professor, Associate Professor and Full Professor-Chair.

Invited oral contributions to conferences:

2016

• 13th European Biological Inorganic Chemistry Conference, EUROBIC, Budapest, Hungary. Organometallic osmium anticancer complexes: insights into their cellular mechanism of action. 
• The Controlling Cancer Summit, 2016, London. Precious metals for cancer treatment - a novel approach

2015         

• The International Chemical Congress of Pacific Basin Societies, Pacifichem 2015, Honolulu, Hawaii, USA. Overcoming platinum resistance using small-molecule antineoplastic agents
•  1^st International Symposium on Clinical and Experimental Metallodrugs in Medicine, CEMM Honolulu, Hawaii, USA. Cellular Redox Balance and the Mechanism of Action of Osmium-organometallic Anticancer Drugs
• 17^th International Conference on Biological Inorganic Chemistry, ICBIC17, Beijing, China. In-cell catalysis: a new approach to cancer treatment
• 13^th International Symposium on Applied Bioinorganic Chemistry ISABC13, Galway, Ireland. In-cell catalysis: a new approach to cancer treatment

 2014

• 12^th European Biological Inorganic Chemistry Conference, EUROBIC, Zurich, Switzerland. Exploiting combination therapy for metal-based anticancer agents
• Dalton Research Conference, University of Warwick, UK. Multi-targeted organometallic anticancer complexes with redox mechanisms of action

 2013         

• WHAM EU-COST Action CM1105, Barcelona, Spain. Novel ROS-inducing Organometallic Anticancer Agents
• Medicinal Redox Inorganic Chemistry Conference. Erlangen, Germany. Novel ROS-inducing Organometallic Anticancer Agents.
• Working Group 4 meeting. EU-COST Action CM1105, Olomouc, Czech Republic. Overcoming cisplatin and oxaliplatin resistance in vitro using small-molecule osmium antineoplastics

 2012        

• First WHAM EU-COST Action CM1105. Granada, Spain. Organometallic anticancer complexes at Warwick
• Postgraduate symposium Department of Chemistry. University of Warwick, UK. Insights into the mechanism of action of ruthenium half-sandwich arene complexes bearing N,N-chelating ligands